Canton Strategic Holdings (CNTN) Other Working Capital Changes (2021 - 2026)
Canton Strategic Holdings posted quarterly Other Working Capital Changes of $1.2 million for Q1 2026, up 183.57% year-on-year from $423103.0 in Q1 2025, and up 353.99% on a QoQ basis from $264280.0 in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Other Working Capital Changes data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 183.57% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 12876.96% YoY), and the FY2025 full-year result was $308055.0, up 800.17% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $1.2 million, up from $264280.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.6 million in Q2 2022 and bottomed at -$898619.0 in Q1 2022.
- The 5-year median for Other Working Capital Changes is -$158387.0 (2024), against an average of $87202.4.
- Peak annual rise in Other Working Capital Changes reached 3023.84% in 2022, while the deepest fall reached 30833.0% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$243496.0 in 2022, then retreated by 23.96% to -$301849.0 in 2023, then declined by 4.27% to -$314746.0 in 2024, then surged by 183.97% to $264280.0 in 2025, then surged by 353.99% to $1.2 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.2 million (Q1 2026), $264280.0 (Q4 2025), and -$106980.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 264,280.00 |
| Dec 31, 2025 | 264,280.00 |
| Sep 30, 2025 | -106,980.00 |
| Sep 30, 2025 | -106,980.00 |
| Jun 30, 2025 | -272,348.00 |
| Jun 30, 2025 | -272,348.00 |
| Mar 31, 2025 | 423,103.00 |
| Mar 31, 2025 | 423,103.00 |
| Dec 31, 2024 | -314,746.00 |
| Dec 31, 2024 | -314,746.00 |
| Sep 30, 2024 | 58,389.00 |
| Sep 30, 2024 | 58,389.00 |
| Jun 30, 2024 | -158,387.00 |
| Jun 30, 2024 | -158,387.00 |
| Mar 31, 2024 | 448,966.00 |
| Mar 31, 2024 | 448,966.00 |
| Dec 31, 2023 | -301,849.00 |
| Dec 31, 2023 | -301,849.00 |
| Sep 30, 2023 | -382,485.00 |
| Sep 30, 2023 | -382,485.00 |
| Jun 30, 2023 | -375,683.00 |
| Jun 30, 2023 | -375,683.00 |
| Mar 31, 2023 | 892,964.00 |
| Mar 31, 2023 | 892,964.00 |
| Dec 31, 2022 | -243,496.00 |
| Dec 31, 2022 | -243,496.00 |
| Sep 30, 2022 | -366,556.00 |
| Sep 30, 2022 | -366,556.00 |
| Jun 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | -898,619.00 |
| Mar 31, 2022 | -898,619.00 |
| Dec 31, 2021 | 66,802.00 |
| Dec 31, 2021 | 66,802.00 |
| Sep 30, 2021 | -1,185.00 |
| Sep 30, 2021 | -1,185.00 |
| Jun 30, 2021 | -55,273.00 |
| Jun 30, 2021 | -55,273.00 |
| Mar 31, 2021 | -42,620.00 |
| Mar 31, 2021 | -42,620.00 |